Pics 6: Lymphoid/PCD Flashcards
HL subtypes and frequency of each
Difference between cHL and NLPHL
New name for NLPHL
NLPBCL
Early stage HL: prognostic markers
GHSG vs EORTC
Prognostic in Advanced stage cHL
PET Deauville scores
Early stage cHL, favourable
4 options, which trials
Early stage HL, unfavourable
4 options, trials
Advanced stage cHL
2 main options in 2024
What were the prior 3 options
HL conclusions 1
HL early stage conclusions
HL advanced stage conclusions, R/R
New therapies in HL, conclusions
WM/LPL DDX
Special toxicities of drugs used in WM
Ritux
Flu/Clad
Benda
Bortez
Ibrutinib
1L treatment of WM
2nd line
MAG neuropathy
Bing Neel
Intolerant or refractory to Ibrutinib
AL amyloid staging tests
AL amyloid algorithm for workup
AL amyloid AutoSCT transplant eligibility
AL amyloid treatment approach
POEMS diagnostic criteria
Natural history of MM
MGUS risk stratification, risk groups, recommended monitoring
IMWG criteria for MGUS/SMM/MM
MGRS types
Glomerular vs Tuuloisterstitial vs vascular
Which 2 types deposit everywhere?
SMM what is the 20-20-20 rule?
Risks of progression
R-ISS for MM
MM treatment paradigm, phases of therapy for Fit vs Unfit/not Auto
Approved therapies in MM over the years
IMWG response criteria for MM
R/R MM definition
Backbones of therapy for MM early relapse
Plasmacytoma evaluation and therapy algorithm
Solitary plasmacytoma diagnostic criteria
Solitary bone
Solitary extra medullary
Solitary with minimal marrow involvement
MM
Plasma cell dyscrasia summary slide
Deauville scale for PET uptake
Risk factors for early stage HL
EORTC or GHSG
CVD incidence in HL survivors for RT or anthracycline
Frontline chemo regimens in HL
What drugs are in:
A-AVD
ABVD
escBEACOPP
Longterm followup for HL survivors
MM pathology images